Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H15NO4 |
Molecular Weight | 237.2518 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(C=CC(NC(C)=O)=C1)C(=O)OC
InChI
InChIKey=GOVWOKSKFSBNGD-UHFFFAOYSA-N
InChI=1S/C12H15NO4/c1-4-17-11-7-9(13-8(2)14)5-6-10(11)12(15)16-3/h5-7H,4H2,1-3H3,(H,13,14)
Ethopabate is a veterinary drug used in the prophylaxis and treatment of coccidiosis in chickens. It is an arylamide containing one phenyl ring, belonging to monocyclic aromatics, is a very safe drug. It has anticoccidial activity especially against intestinal forms and lacks activity against E. tenella of caecal worms. This drug is a competitor of PABA for absorption by the parasite and interferes with folate synthesis. It has good activity against E. acervulina and some strains of E. maxima and E. brunette. It has been used only in combination with Amprolium first at 4 ppm and later at 40 ppm. This drug has peak activity on 4th day of cycle. Ethopabate is a component of marketed AMPROL PLUS (amprolium, ethopabate), indicated for use as an aid in the prevention of coccidiosis (1) in broiler chickens and (2) in replacement chickens where immunity to coccidiosis is not desired.
Originator
Sources: http://www.drugfuture.com/chemdata/ethopabate.html | https://www.google.com/patents/US5646135
Curator's Comment: # Merck
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0046656 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | AMPROL PLUS Approved UseAMPROL PLUS (amprolium, ethopabate) is intended for use as an aid in the
prevention of coccidiosis (1) in broiler chickens and (2) in replacement chickens
where immunity to coccidiosis is not desired. Launch Date2007 |
PubMed
Title | Date | PubMed |
---|---|---|
The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. | 1982 Apr |
|
Validation of a high-performance liquid chromatographic method with UV detection for the determination of ethopabate residues in poultry liver. | 2008 Nov-Dec |
|
Development and validation of a rapid multi-class method for the confirmation of fourteen prohibited medicinal additives in pig and poultry compound feed by liquid chromatography-tandem mass spectrometry. | 2010 Dec 1 |
Patents
Sample Use Guides
AMPROL PLUS (amprolium, ethopabate) should be thoroughly and evenly mixed in the feed. AMPROL PLUS may be used
to manufacture a Type C medicated feed in the concentration range of 0.0125% - 0.025% amprolium and 0.0004% ethopabate.
One pound of AMPROL PLUS should be mixed with one ton of non-medicated feed to produce a Type C medicated
feed containing 0.0125% amprolium / 0.0004% ethopabate. One pound of AMPROL PLUS and one pound of AMPROL
(amprolium) 25% mixed with one ton of non-medicated feed will produce a feed containing 0.025% amprolium and
0.0004% ethopabate.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/938765
The short-term toxicity (EC50 respectively LC50 after 2 or 4 days) of 13 feed additives was determined to 4 freshwater organisms of different trophical levels: Chlorella pyrenoidosa, Daphnia magna, Lebistes reticulatus and Salmo gairdneri. ethopabate, furazolidone and zoalene proved to be little toxic (LC(EC)50 greater than 10 mg/1).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 558.58
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
||
|
WHO-VATC |
QP51AX17
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
||
|
CFR |
21 CFR 556.260
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1314353
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL458769
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
1262801
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
300000034592
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
ETHOPABATE
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
F4X3L6068O
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
200-414-3
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
6034
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
59-06-3
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
DTXSID6046264
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | |||
|
m5068
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
C76420
Created by
admin on Fri Dec 15 15:21:28 GMT 2023 , Edited by admin on Fri Dec 15 15:21:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY